125 related articles for article (PubMed ID: 3127219)
1. Systemic infection and colonization with and without prophylactic norfloxacin use over time in the granulocytopenic, acute leukemia patient.
Karp JE; Dick JD; Merz WG
Eur J Cancer Clin Oncol; 1988; 24 Suppl 1():S5-13. PubMed ID: 3127219
[TBL] [Abstract][Full Text] [Related]
2. Infection management during antileukemia treatment-induced granulocytopenia: the role for oral norfloxacin prophylaxis against infections arising from the gastrointestinal tract.
Karp JE; Merz WG; Hendricksen C; Laughon B; Redden T; Bamberger BJ; Bartlett JG; Saral R; Burke PJ
Scand J Infect Dis Suppl; 1986; 48():66-78. PubMed ID: 3535055
[TBL] [Abstract][Full Text] [Related]
3. Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. A randomized, double-blind, placebo-controlled trial.
Karp JE; Merz WG; Hendricksen C; Laughon B; Redden T; Bamberger BJ; Bartlett JG; Saral R; Burke PJ
Ann Intern Med; 1987 Jan; 106(1):1-7. PubMed ID: 3538962
[TBL] [Abstract][Full Text] [Related]
4. Chemoprophylaxis of bacterial infections in granulocytopenic cancer patients using norfloxacin.
Casali A; Verri C; Paoletti G; Tropea F; Modugno G; Frasca AM; Ameglio F; Tonachella R; Gallo Curcio C
Chemioterapia; 1988 Oct; 7(5):327-9. PubMed ID: 3066518
[TBL] [Abstract][Full Text] [Related]
5. Prevention of gram-negative bacterial infection in granulocytopenic patients: a randomized study comparing oral norfloxacin with gentamycin.
Nemet D; Kalenic S; Badanjak A; Bogdanic V; Davila N; Francetić I; Labar B
Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():105. PubMed ID: 2697389
[No Abstract] [Full Text] [Related]
6. Norfloxacin versus cotrimoxazole for infection prophylaxis in granulocytopenic patients with acute leukemia. A prospective randomized study.
Orlandi E; Navarra A; Cruciani M; Caldera D; Morra E; Castagnola C; Concia E; Bernasconi C
Haematologica; 1990; 75(3):296-8. PubMed ID: 2227631
[TBL] [Abstract][Full Text] [Related]
7. Parenteral antibiotic prophylaxis of bacterial infections does not improve cost-efficacy of oral norfloxacin in cirrhotic patients with gastrointestinal bleeding.
Sàbat M; Kolle L; Soriano G; Ortiz J; Pamplona J; Novella MT; Villanueva C; Sainz S; Torras J; Balanzó J; Guarner C
Am J Gastroenterol; 1998 Dec; 93(12):2457-62. PubMed ID: 9860409
[TBL] [Abstract][Full Text] [Related]
8. Infection and transfusion therapy in acute leukaemia.
Ho WG; Winston DJ
Clin Haematol; 1986 Aug; 15(3):873-904. PubMed ID: 3096621
[TBL] [Abstract][Full Text] [Related]
9. [A comparison of nystatin with norfloxacin for prevention of infection after consolidation therapy in patients with acute leukemia or autologous bone marrow transplantation: a randomized study].
Sampi K; Maseki N; Hattori M
Gan To Kagaku Ryoho; 1992 Jun; 19(6):823-6. PubMed ID: 1605660
[TBL] [Abstract][Full Text] [Related]
10. Colonization with antibiotic-resistant Gram-negative bacilli in the neonatal intensive care unit.
Toltzis P
Minerva Pediatr; 2003 Oct; 55(5):385-93. PubMed ID: 14608262
[TBL] [Abstract][Full Text] [Related]
11. Norfloxacin prophylaxis for neutropenic patients undergoing bone marrow transplantation.
Menichetti F; Felicini R; Bucaneve G; Aversa F; Greco M; Pasquarella C; Moretti MV; Del Favero A; Martelli MF
Bone Marrow Transplant; 1989 Sep; 4(5):489-92. PubMed ID: 2790326
[TBL] [Abstract][Full Text] [Related]
12. Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage.
Fernández J; Ruiz del Arbol L; Gómez C; Durandez R; Serradilla R; Guarner C; Planas R; Arroyo V; Navasa M
Gastroenterology; 2006 Oct; 131(4):1049-56; quiz 1285. PubMed ID: 17030175
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic administration of oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemias.
Liso V; Specchia G; Pavone V; Pansini N; Capalbo S; Ostuni A; Mastria A; Colucci A; Costantino G
J Chemother; 1989 Jul; 1(4 Suppl):1297-9. PubMed ID: 16312873
[No Abstract] [Full Text] [Related]
14. Manipulation of the oropharyngeal and intestinal microflora by norfloxacin: microbiological and clinical aspects.
Edlund C; Nord CE
Scand J Infect Dis Suppl; 1988; 56():14-21. PubMed ID: 3074461
[TBL] [Abstract][Full Text] [Related]
15. Emergence of resistance as a consequence of antimicrobial prophylaxis in immunocompromised patients.
Dejace P; Klastersky J
Scand J Infect Dis Suppl; 1986; 49():165-71. PubMed ID: 3547622
[TBL] [Abstract][Full Text] [Related]
16. [The duration of the effect of norfloxacin on the fecal flora in cirrhosis patients].
Soriano G; Guarner C; Tomás A; Anguera A; Mirelis B; Fernández C; Herrero M; Alonso C; Vilardell F
Rev Esp Enferm Dig; 1992 May; 81(5):322-6. PubMed ID: 1616740
[TBL] [Abstract][Full Text] [Related]
17. World-wide clinical experience with norfloxacin: efficacy and safety.
Wang C; Sabbaj J; Corrado M; Hoagland V
Scand J Infect Dis Suppl; 1986; 48():81-9. PubMed ID: 3535057
[TBL] [Abstract][Full Text] [Related]
18. Ciprofloxacin and norfloxacin for selective decontamination in patients with severe granulocytopenia.
Maschmeyer G; Haralambie E; Gaus W; Kern W; Dekker AW; De Vries-Hospers HG; Sizoo W; König W; Gutzler F; Daenen S
Infection; 1988; 16(2):98-104. PubMed ID: 3286509
[TBL] [Abstract][Full Text] [Related]
19. Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin.
Novella M; Solà R; Soriano G; Andreu M; Gana J; Ortiz J; Coll S; Sàbat M; Vila MC; Guarner C; Vilardell F
Hepatology; 1997 Mar; 25(3):532-6. PubMed ID: 9049193
[TBL] [Abstract][Full Text] [Related]
20. The tolerability profile of prophylactic norfloxacin in neutropenic patients.
Corrado ML; Struble WE; Hesney M
Eur J Cancer Clin Oncol; 1988; 24 Suppl 1():S29-33. PubMed ID: 3280325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
